These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28957553)

  • 21. Tight control of rheumatoid arthritis in a resource-constrained setting: a randomized controlled study comparing the clinical disease activity index and simplified disease activity index.
    Hodkinson B; Musenge E; Tikly M
    Rheumatology (Oxford); 2015 Jun; 54(6):1033-8. PubMed ID: 25431484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of Disease Activity Scores and Routine Assessment of Patient Index Data (RAPID3) on a Multidimensional Health Assessment Questionnaire in Patients With Rheumatoid Arthritis: A Saudi Experience.
    Abdulaziz S; Almaqati AS; Komo K; Alahmadi A
    Cureus; 2023 Sep; 15(9):e44982. PubMed ID: 37822428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt.
    Martins FM; da Silva JA; Santos MJ; Vieira-Sousa E; Duarte C; Santos H; Costa JA; Pimentel-Santos FM; Cunha I; Cunha Miranda L; Nóvoa T; Cruz M; Bernardes M; Araujo D; Pereira Silva JA; Silva JC; Branco JC; Gomes JA; Faustino A; Fonseca JE; Canhão H
    Rheumatology (Oxford); 2015 Feb; 54(2):286-91. PubMed ID: 25173347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hip score and disease activity correlation in patients with rheumatoid arthritis after total hip arthroplasty.
    Wakabayashi H; Hasegawa M; Yoshida K; Nishioka K; Sudo A
    Int Orthop; 2013 Jul; 37(7):1245-50. PubMed ID: 23640680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials.
    Bergman M; Buch MH; Tanaka Y; Citera G; Bahlas S; Wong E; Song Y; Zueger P; Ali M; Strand V
    Rheumatol Ther; 2022 Dec; 9(6):1517-1529. PubMed ID: 36125701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RAPID3 scores and hand outcome measurements in RA patients: a preliminary study.
    Qorolli M; Hundozi-Hysenaj H; Rexhepi S; Rehxepi B; Grazio S
    Clin Rheumatol; 2017 Jun; 36(6):1379-1385. PubMed ID: 28028685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.
    Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
    RMD Open; 2019; 5(2):e001050. PubMed ID: 31908842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI.
    Gaujoux-Viala C; Mouterde G; Baillet A; Claudepierre P; Fautrel B; Le Loët X; Maillefert JF
    Joint Bone Spine; 2012 Mar; 79(2):149-55. PubMed ID: 21680221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
    Smolen JS; Aletaha D
    Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of the Multi-Biomarker Disease Activity Score With Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta-Analysis.
    Johnson TM; Register KA; Schmidt CM; O'Dell JR; Mikuls TR; Michaud K; England BR
    Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1459-1472. PubMed ID: 30320973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reexamination of the assessment criteria for rheumatoid arthritis disease activity based on comparison of the Disease Activity Score 28 with other simpler assessment methods.
    Fujiwara M; Kita Y
    Mod Rheumatol; 2013 Mar; 23(2):260-8. PubMed ID: 22546955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical value of MDHAQ for disease activity assessment in patients with rheumatoid arthritis].
    Yang M; Wang Y; Xie QB; Cen XR; Yin G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):285-8. PubMed ID: 25924447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
    Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
    Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of composite disease activity indices for rheumatoid arthritis.
    Matsui T; Kuga Y; Nishino J; Kaneko A; Eto Y; Tohma S
    Mod Rheumatol; 2011 Apr; 21(2):134-43. PubMed ID: 20972600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-year maintenance with routine assessment of patient index data 3-based remission may inhibit radiographic progression in patients with rheumatoid arthritis treated with routine clinical therapy: A retrospective comparison of radiographic outcome and its prognostic factors between maintained remissions with patient-reported outcome index and physician-oriented disease activity indices.
    Katayama K; Okubo T; Sato T; Kamiya K; Fukai R; Abe S; Ito H; Makino Y; Kamishima T
    Mod Rheumatol; 2016 Nov; 26(6):817-827. PubMed ID: 26915909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability and validity of CDAI and SDAI indices in comparison to DAS-28 index in Moroccan patients with rheumatoid arthritis.
    Slama IB; Allali F; Lakhdar T; El Kabbaj S; Medrare L; Ngeuleu A; Rkain H; Hajjaj-Hassouni N
    BMC Musculoskelet Disord; 2015 Sep; 16():268. PubMed ID: 26420567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electronic eRAPID3 (Routine Assessment of Patient Index Data): opportunities and complexities.
    Pincus T
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S49-S53. PubMed ID: 27762206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of three rheumatoid arthritis disease activity scores in clinical routine.
    Rintelen B; Sautner J; Haindl PM; Andel I; Maktari A; Leeb BF
    Scand J Rheumatol; 2009; 38(5):336-41. PubMed ID: 19585379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dickkopf 1 protein circulating levels as a possible biomarker of functional disability and chronic damage in patients with rheumatoid arthritis.
    Santos AM; Saldarriaga EL; Giraldo-Bustos R; Ballesteros-Muñoz JG; Rueda JC; Cuervo FM; Angarita JI; Vásquez AY; Arias-Correal S; González CA; Santos-Moreno P; Londono J
    Clin Rheumatol; 2018 Mar; 37(3):795-801. PubMed ID: 29282619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).
    Salaffi F; Cimmino MA; Leardini G; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2009; 27(4):552-9. PubMed ID: 19772784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.